BRIEF — Novo's Sogroya Gets Positive CHMP Opinion In Europe For Children With ISS
Sept 18 (Reuters) — Novo Nordisk A/S: Novo’s Once-weekly Sogroya® (Somapacitan) Receives Positive Chmp Opinion In Europe For Children With Idiopathic Short Stature (Unexplained Shortness) Source text:... Further company coverage: NOVOb.CO (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;)